Eternatear has a total of 15 patents globally, out of which 3 have been granted. Of these 15 patents, more than 86% patents are active. The United States of America is where Eternatear has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Eternatear.
Eternatear was founded in 2018. Eternatear is a next-generation OTC artificial tear that provides long-term relief to millions of individuals suffering from progressive dry eye, a painful and often debilitating condition.
Do read about some of the most popular patents of Eternatear which have been covered by us in this article and also you can find Eternatear patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Eternatear patent portfolio.
How many patents do the Founder and CEO of Eternatear have?
The Founder and CEO Tim Willis have 0 patents.
How many patents does Eternatear have?
Eternatear has a total of 15 patents globally. These patents belong to 2 unique patent families. Out of 15 patents, 13 patents are active.
How Many Patents did Eternatear File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Eternatear Applications Filed | Eternatear Patents Granted |
| 2023 | 3 | 2 |
| 2022 | 3 | 1 |
| 2021 | 2 | – |
| 2019 | 7 | – |
How many Eternatear patents are Alive/Dead?
Worldwide Patents
How Many Patents did Eternatear File in Different Countries?
Countries in which Eternatear Filed Patents
| Country | Patent |
| United States Of America | 6 |
| India | 1 |
| Hong Kong (S.A.R.) | 1 |
| Canada | 1 |
| Japan | 1 |
| China | 1 |
| Brazil | 1 |
| Europe | 1 |
Where are Research Centers of Eternatear Patents Located?
The Research Centers of Eternatear Patents is the United States of America.
List of Eternatear patents
| Eternatear Patents | Title |
| US11679079B1 | Ophthalmic Formulations And Related Methods |
| US11679078B1 | Ophthalmic Formulations And Related Methods |
| US11278493B2 | Ophthalmic Formulations Providing Durable Ocular Lubrication |
| US20230320980A1 | Ophthalmic Formulations And Related Methods |
| US20230310312A1 | Ophthalmic Formulations And Related Methods |
| US20210386671A1 | Ophthalmic Formulations Providing Durable Ocular Lubrication |
| EP3893842A1 | Ophthalmic Formulations Providing Durable Ocular Lubrication |
| CN113423387A | Ophthalmic Formulations Providing Durable Ocular Lubrication |
| CA3120453A1 | Ophthalmic Formulations Providing Durable Ocular Lubrication |
| JP2022510735A | Ophthalmic Formulations That Provide Long-Lasting Eye Lubrication |
| HK40060657A | Ophthalmic Formulations Providing Durable Ocular Lubrication |
| IN202117030145A | Ophthalmic Formulations Providing Durable Ocular Lubrication |
| BR112021011210A2 | Ophthalmic Formulations That Provide Durable Eye Lubrication |
| WO2023172498A1 | Ophthalmic Formulations And Related Methods |
| WO2020123362A1 | Ophthalmic Formulations Providing Durable Ocular Lubrication |
What are Eternatear key innovation segments?
What Technologies are Covered by Eternatear?
The chart below distributes patents filed by Eternatear